Anita H. Clayton

Original Research

Assessing the Onset of Antidepressant-Induced Sexual Dysfunction Using Interactive Voice Response Technology

Original Research

Bupropion Extended Release Compared With Escitalopram: Effects on Sexual Functioning and Antidepressant Efficacy in 2 Randomized, Double-Blind, Placebo-Controlled Studies.

Article

Consensus Statement and Research Needs: The Role of Dopamine and Norepinephrine in Depression and Antidepressant Treatment

Original Research

Desvenlafaxine 50 and 100 mg/d Versus Placebo for the Treatment of Major Depressive Disorder: A Phase 4, Randomized Controlled Trial

Article

Distressing Sexual Problems in United States Women Revisited: Prevalence After Accounting for Depression

Article

Efficacy and Safety of Desvenlafaxine 50 mg/d in a Randomized, Placebo-Controlled Study of Perimenopausal and Postmenopausal Women With Major Depressive Disorder

ASCP Corner

Female Sexual Dysfunctions: What Controversy?

ASCP Corner

Gender Differences in Clinical Psychopharmacology

Original Research

Lurasidone and Sexual Function

As you probably know, sexual dysfunction is a common side effect of antidepressants and antipsychotics. This secondary analysis of an RCT examines whether the atypical antipsychotic lurasidone was linked...

Article

Major Depressive Disorder, Antidepressants, and Sexual Dysfunction.

Original Research

A Placebo-Controlled Trial of Bupropion SR as an Antidote for Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction

Original Research

Prevalence of Sexual Dysfunction Among Newer Antidepressants

Academic Highlights

Recent Advances in the Treatment of Depression in the Presence of Physical Symptoms.

Article

Recognition and Assessment of Sexual Dysfunction Associated With Depression

Original Research

Substitution of an SSRI With Bupropion Sustained Release Following SSRI-Induced Sexual Dysfunction

Original Research

Symptoms of Sexual Dysfunction in Patients Treated for Major Depressive Disorder: A Meta-Analysis Comparing Selegiline Transdermal System and Placebo Using a Patient-Rated Scale

Article

Prevalence of Substance Misuse in New Patients in an Outpatient Psychiatry Clinic Using a Prescription Monitoring Program

The purpose of this study was to investigate the value of a prescription monitoring program in identifying prescription drug misuse among patients presenting to a resident physicians' outpatient psychiatry...

Letter to the Editor

Onset of Obstructive Sleep Apnea After Initiation of Psychotropic Agents

Article

Depression or Menopause? Presentation and Management of Major Depressive Disorder in Perimenopausal and Postmenopausal Women

In this review article, examine the risk of depression onset in perimenopausal and postmenopausal women and find out how to screen for and manage depression in your perimenopausal and...

Educational Activity

Treating Depression Complicated by Comorbid Medical Illness or Anxiety

Educational Activity

Understanding Antidepressant Mechanism of Action and Its Effect on Efficacy and Safety

Article

Recognition and Assessment of Sexual Dysfunction Associated With Depression

Original Research

Effect of Zuranolone vs Placebo in MDD

This phase 3 RCT found significant improvement in depressive symptoms with zuranolone beginning at day 3 of treatment.

Supplement

The GABA Pathway and New Clinical Trial Data in MDD and PPD

Studies evaluating neuroactive steroid GABA-A receptor positive allosteric modulators demonstrate promising results for the treatment of MDD and PPD.

Assessing the Onset of Antidepressant-Induced Sexual Dysfunction Using Interactive Voice Response Technology

Bupropion Extended Release Compared With Escitalopram: Effects on Sexual Functioning and Antidepressant Efficacy in 2 Randomized, Double-Blind, Placebo-Controlled Studies.

Consensus Statement and Research Needs: The Role of Dopamine and Norepinephrine in Depression and Antidepressant Treatment

Desvenlafaxine 50 and 100 mg/d Versus Placebo for the Treatment of Major Depressive Disorder: A Phase 4, Randomized Controlled Trial

Distressing Sexual Problems in United States Women Revisited: Prevalence After Accounting for Depression

Efficacy and Safety of Desvenlafaxine 50 mg/d in a Randomized, Placebo-Controlled Study of Perimenopausal and Postmenopausal Women With Major Depressive Disorder

Female Sexual Dysfunctions: What Controversy?

Gender Differences in Clinical Psychopharmacology

Lurasidone and Sexual Function

Major Depressive Disorder, Antidepressants, and Sexual Dysfunction.

A Placebo-Controlled Trial of Bupropion SR as an Antidote for Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction

Prevalence of Sexual Dysfunction Among Newer Antidepressants

Recent Advances in the Treatment of Depression in the Presence of Physical Symptoms.

Recognition and Assessment of Sexual Dysfunction Associated With Depression

Substitution of an SSRI With Bupropion Sustained Release Following SSRI-Induced Sexual Dysfunction

Symptoms of Sexual Dysfunction in Patients Treated for Major Depressive Disorder: A Meta-Analysis Comparing Selegiline Transdermal System and Placebo Using a Patient-Rated Scale

Prevalence of Substance Misuse in New Patients in an Outpatient Psychiatry Clinic Using a Prescription Monitoring Program

Onset of Obstructive Sleep Apnea After Initiation of Psychotropic Agents

Depression or Menopause? Presentation and Management of Major Depressive Disorder in Perimenopausal and Postmenopausal Women

Treating Depression Complicated by Comorbid Medical Illness or Anxiety

Understanding Antidepressant Mechanism of Action and Its Effect on Efficacy and Safety

Recognition and Assessment of Sexual Dysfunction Associated With Depression

Effect of Zuranolone vs Placebo in MDD

The GABA Pathway and New Clinical Trial Data in MDD and PPD

ELSEWHERE:

FOLLOW US:

Anita H. Clayton

Assessing the Onset of Antidepressant-Induced Sexual Dysfunction Using Interactive Voice Response Technology

Bupropion Extended Release Compared With Escitalopram: Effects on Sexual Functioning and Antidepressant Efficacy in 2 Randomized, Double-Blind, Placebo-Controlled Studies.

Consensus Statement and Research Needs: The Role of Dopamine and Norepinephrine in Depression and Antidepressant Treatment

Desvenlafaxine 50 and 100 mg/d Versus Placebo for the Treatment of Major Depressive Disorder: A Phase 4, Randomized Controlled Trial

Distressing Sexual Problems in United States Women Revisited: Prevalence After Accounting for Depression

Efficacy and Safety of Desvenlafaxine 50 mg/d in a Randomized, Placebo-Controlled Study of Perimenopausal and Postmenopausal Women With Major Depressive Disorder

Female Sexual Dysfunctions: What Controversy?

Gender Differences in Clinical Psychopharmacology

Lurasidone and Sexual Function

Major Depressive Disorder, Antidepressants, and Sexual Dysfunction.

A Placebo-Controlled Trial of Bupropion SR as an Antidote for Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction

Prevalence of Sexual Dysfunction Among Newer Antidepressants

Recent Advances in the Treatment of Depression in the Presence of Physical Symptoms.

Recognition and Assessment of Sexual Dysfunction Associated With Depression

Substitution of an SSRI With Bupropion Sustained Release Following SSRI-Induced Sexual Dysfunction

Symptoms of Sexual Dysfunction in Patients Treated for Major Depressive Disorder: A Meta-Analysis Comparing Selegiline Transdermal System and Placebo Using a Patient-Rated Scale

Prevalence of Substance Misuse in New Patients in an Outpatient Psychiatry Clinic Using a Prescription Monitoring Program

Onset of Obstructive Sleep Apnea After Initiation of Psychotropic Agents

Depression or Menopause? Presentation and Management of Major Depressive Disorder in Perimenopausal and Postmenopausal Women

Treating Depression Complicated by Comorbid Medical Illness or Anxiety

Understanding Antidepressant Mechanism of Action and Its Effect on Efficacy and Safety

Recognition and Assessment of Sexual Dysfunction Associated With Depression

Effect of Zuranolone vs Placebo in MDD

The GABA Pathway and New Clinical Trial Data in MDD and PPD

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles